Genetron Holdings (Genetron Holdings) Capex-to-Operating-Income : 0.00 (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Genetron Holdings's Capital Expenditure for the three months ended in Jun. 2022 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2022 was $-24.10 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Genetron Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Genetron Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Capex-to-Operating-Income Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Capex-to-Operating-Income

Get a 7-Day Free Trial

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
Capex-to-Operating-Income	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Genetron Holdings's Capex-to-Operating-Income

For the Diagnostics & Research subindustry, Genetron Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetron Holdings's Capex-to-Operating-Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's Capex-to-Operating-Income falls into.

Genetron Holdings Capex-to-Operating-Income Calculation

Genetron Holdings's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-11.782)	/	-90.598
	=	N/A

Genetron Holdings's Capex-to-Operating-Income for the quarter that ended in Jun. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-24.102
	=	N/A

Genetron Holdings (NAS:GTH) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Genetron Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.